Moderna Inc (0QF)

128.96
-6.86(-5.05%)
  • Volume:
    27,619
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    124.66 - 138.52
  • Type:Equity
  • Market:Germany
  • ISIN:US60770K1079
  • WKN:A2N9D9

0QF Comments

What is your sentiment on Moderna?
or
Market is currently closed. Voting is open during market hours.

All Comments

(10231)
  • Come to papa
    0
    • NEW YORK, NY and CAMBRIDGE, MA / ACCESSWIRE / May 18, 2022 / The nonprofit scientific research organization IAVI and Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the first participant screenings are soon to start for a Phase I clinical trial of an mRNA HIV vaccine antigen (mRNA-1644) at the Center for Family Health Research (CFHR) in Kigali, Rwanda, and The Aurum Institute in Tembisa, South Africa.
      4
      • 'cause of the new variant of covid, Asians are losing their hair (I'm seriously), ok?
        3
        • cmon baby 10
          0
          • Now buy…
            4
            • why is this not scrambling yet ???
              0
              • When number of Shares Outstanding is gradually shrinking.. I love it
                3
                • "Moderna sees higher COVID vaccine sales later this year" https://www.investing.com/news/stock-market-news/moderna-keeps-fullyear-covid-vaccine-sales-view-unchanged-2816954
                  4
                  • Great Stock. NOT
                    1
                    • it is. you just don't know it yet
                      2
                  • Buy - 130.80… hold for more…
                    3
                    • Come to daddy
                      3
                      • Now at CNBC ~ Covid’s toll in the U.S. reaches a once unfathomable number: 1 million deaths ~ PUBLISHED WED, MAY 4 20224:37 PM EDT
                        3
                        • u can short this company but the 1M never again
                          2
                      • with this earning report moderna should be taking off. what is wrong with people how much more does a company have to show you for you to believe its sold.
                        1
                        • excellent results and the stock price turned negative... why?
                          1
                          • gp ahead keep knocking moderna because you don't like there vaccine.moderna is not a one trick pony. they have a lot in the pipe line
                            3
                            • Most of the investors long or short do not know this.
                              2
                          • Very strong earnings, my congrats. 'Moderna's 2022 APAs for product sales are approximately $21 billion. Moderna believes that COVID market dynamics will result in sales slightly larger in the second half of 2022 than in the first half.'
                            2
                            • Bad earnings coming !!!!!
                              6
                              • expectation is 5.27 EPS, too low, I think they will beat it with some good margin. 2021 average quarterly is 7.2 EPS
                                0
                              • As announced last quarter, the Board of Directors authorized a share repurchase program for $3 billion
                                2
                            • Pfizer had great earnings, that could be bad for Maderna
                              3
                              • More internals (A)s than (D)s predict bullish earnings++
                                2
                                • Evil company! Big pharma wants you sick.
                                  3
                                  • The fact that kids are having liver issues can be very bad for these vaccine companies, still don’t know all the side effects of this vaccine
                                    0
                                    • I can see this below $100 on Earnings
                                      0
                                      • I see a very bad earnings coming out
                                        0
                                        • Buy now!
                                          3
                                          • 'We are proud to share that we have initiated our EUA submission for authorization for our COVID-19 vaccine for young children," said Stéphane Bancel, Chief Executive Officer of Moderna. "We believe mRNA-1273 will be able to safely protect these children against SARS-CoV-2, which is so important in our continued fight against COVID-19 and will be especially welcomed by parents and caregivers.'
                                            4